Actual Medicinal Product (AMP) Lariam 250mg tablets (Neon Healthcare Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Sensitive to moisture, photolytic - protect from light

Provenance

This compatibility recommendation is derived from Lariam 250mg tablets (Neon Healthcare Ltd).

Generic
Mefloquine
Formulation
Mefloquine 250mg tablets
  • Mefloquine
    • Mefloquine 250mg tablets
      • Lariam 250mg tablets (Neon Healthcare Ltd)



Related Formulations (1)